Pharma has much to gain from leveraging ... If we had a traditional model, we may find it challenging to draw out ideas from our younger workforce. Biopharma start-ups need to look for partnership ...

I write about business model strategy and execution across healthcare. The pharmaceutical industry ... In a more centralized decision-making environment, it is also evident that field staff ...

The concept of managing risk through scale is based on portfolio theory--the idea that by increasing ... The current pharma model of high-quality, high-cost development cannot be scaled to the ...

At the start of each of the last five years, the share price of Alkermes has increased. It’s the kind of steady trajectory ...

Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.) ...